Literature DB >> 25556247

Diverse roles for T-bet in the effector responses required for resistance to infection.

Gretchen Harms Pritchard1, Aisling O'Hara Hall1, David A Christian1, Sagie Wagage1, Qun Fang1, Gaia Muallem1, Beena John1, Arielle Glatman Zaretsky1, William G Dunn1, Jacqueline Perrigoue1, Steven L Reiner2, Christopher A Hunter3.   

Abstract

The transcription factor T-bet has been most prominently linked to NK and T cell production of IFN-γ, a cytokine required for the control of a diverse array of intracellular pathogens. Indeed, in mice challenged with the parasite Toxoplasma gondii, NK and T cell responses are characterized by marked increases of T-bet expression. Unexpectedly, T-bet(-/-) mice infected with T. gondii develop a strong NK cell IFN-γ response that controls parasite replication at the challenge site, but display high parasite burdens at secondary sites colonized by T. gondii and succumb to infection. The loss of T-bet had a modest effect on T cell production of IFN-γ but did not impact on the generation of parasite-specific T cells. However, the absence of T-bet resulted in lower T cell expression of CD11a, Ly6C, KLRG-1, and CXCR3 and fewer parasite-specific T cells at secondary sites of infection, associated with a defect in parasite control at these sites. Together, these data highlight T-bet-independent pathways to IFN-γ production and reveal a novel role for this transcription factor in coordinating the T cell responses necessary to control this infection in peripheral tissues.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25556247      PMCID: PMC4297724          DOI: 10.4049/jimmunol.1401617

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  72 in total

1.  In the absence of endogenous IFN-gamma, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection.

Authors:  T M Scharton-Kersten; T A Wynn; E Y Denkers; S Bala; E Grunvald; S Hieny; R T Gazzinelli; A Sher
Journal:  J Immunol       Date:  1996-11-01       Impact factor: 5.422

2.  Contribution of interleukin-12 (IL-12) and the CD28/B7 and CD40/CD40 ligand pathways to the development of a pathological T-cell response in IL-10-deficient mice.

Authors:  Ulrike Wille; Eric N Villegas; Linden Craig; Robert Peach; Christopher A Hunter
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

3.  Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells.

Authors:  Susanne J Szabo; Brandon M Sullivan; Claudia Stemmann; Abhay R Satoskar; Barry P Sleckman; Laurie H Glimcher
Journal:  Science       Date:  2002-01-11       Impact factor: 47.728

4.  Protective immunity to genital herpes simplex [correction of simpex] virus type 2 infection is mediated by T-bet.

Authors:  Alexandra Svensson; Inger Nordström; Jia-Bin Sun; Kristina Eriksson
Journal:  J Immunol       Date:  2005-05-15       Impact factor: 5.422

5.  The transcription factor T-bet is induced by multiple pathways and prevents an endogenous Th2 cell program during Th1 cell responses.

Authors:  Jinfang Zhu; Dragana Jankovic; Andrew J Oler; Gang Wei; Suveena Sharma; Gangqing Hu; Liying Guo; Ryoji Yagi; Hidehiro Yamane; George Punkosdy; Lionel Feigenbaum; Keji Zhao; William E Paul
Journal:  Immunity       Date:  2012-10-04       Impact factor: 31.745

6.  Antigen-driven effector CD8 T cell function regulated by T-bet.

Authors:  Brandon M Sullivan; Amy Juedes; Susanne J Szabo; Matthias von Herrath; Laurie H Glimcher
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-12       Impact factor: 11.205

7.  CXCR3-deficiency protects influenza-infected CCR5-deficient mice from mortality.

Authors:  Shaza A Fadel; Shannon K Bromley; Benjamin D Medoff; Andrew D Luster
Journal:  Eur J Immunol       Date:  2008-12       Impact factor: 5.532

8.  Interleukin-12 enhances murine survival against acute toxoplasmosis.

Authors:  I A Khan; T Matsuura; L H Kasper
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

9.  Generalized Lévy walks and the role of chemokines in migration of effector CD8+ T cells.

Authors:  Tajie H Harris; Edward J Banigan; David A Christian; Christoph Konradt; Elia D Tait Wojno; Kazumi Norose; Emma H Wilson; Beena John; Wolfgang Weninger; Andrew D Luster; Andrea J Liu; Christopher A Hunter
Journal:  Nature       Date:  2012-06-28       Impact factor: 49.962

Review 10.  Natural killer cells as an initial defense against pathogens.

Authors:  Melissa B Lodoen; Lewis L Lanier
Journal:  Curr Opin Immunol       Date:  2006-06-12       Impact factor: 7.486

View more
  25 in total

1.  The Transcription Factor T-bet Limits Amplification of Type I IFN Transcriptome and Circuitry in T Helper 1 Cells.

Authors:  Shigeru Iwata; Yohei Mikami; Hong-Wei Sun; Stephen R Brooks; Dragana Jankovic; Kiyoshi Hirahara; Atsushi Onodera; Han-Yu Shih; Takeshi Kawabe; Kan Jiang; Toshinori Nakayama; Alan Sher; John J O'Shea; Fred P Davis; Yuka Kanno
Journal:  Immunity       Date:  2017-06-13       Impact factor: 31.745

2.  Fucosyltransferase Induction during Influenza Virus Infection Is Required for the Generation of Functional Memory CD4+ T Cells.

Authors:  Roberto Tinoco; Florent Carrette; Monique L Henriquez; Yu Fujita; Linda M Bradley
Journal:  J Immunol       Date:  2018-02-28       Impact factor: 5.422

3.  Cytokine- and TCR-Mediated Regulation of T Cell Expression of Ly6C and Sca-1.

Authors:  Jonathan H DeLong; Aisling O'Hara Hall; Christoph Konradt; Gaia M Coppock; Jeongho Park; Gretchen Harms Pritchard; Christopher A Hunter
Journal:  J Immunol       Date:  2018-01-22       Impact factor: 5.422

4.  T-bet-mediated Tim-3 expression dampens monocyte function during chronic hepatitis C virus infection.

Authors:  Wenjing Yi; Peixin Zhang; Yan Liang; Yun Zhou; Huanjun Shen; Chao Fan; Jonathan P Moorman; Zhi Q Yao; Zhansheng Jia; Ying Zhang
Journal:  Immunology       Date:  2016-12-07       Impact factor: 7.397

5.  Impact of secondary TCR engagement on the heterogeneity of pathogen-specific CD8+ T cell response during acute and chronic toxoplasmosis.

Authors:  Lindsey A Shallberg; Anthony T Phan; David A Christian; Joseph A Perry; Breanne E Haskins; Daniel P Beiting; Tajie H Harris; Anita A Koshy; Christopher A Hunter
Journal:  PLoS Pathog       Date:  2022-06-21       Impact factor: 7.464

6.  Sufficiency of CD40 activation and immune checkpoint blockade for T cell priming and tumor immunity.

Authors:  Alexander H Morrison; Mark S Diamond; Ceire A Hay; Katelyn T Byrne; Robert H Vonderheide
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-25       Impact factor: 11.205

Review 7.  The evolving role of T-bet in resistance to infection.

Authors:  Gretchen Harms Pritchard; Ross M Kedl; Christopher A Hunter
Journal:  Nat Rev Immunol       Date:  2019-06       Impact factor: 53.106

8.  The Diverse Role of NK Cells in Immunity to Toxoplasma gondii Infection.

Authors:  Jason P Gigley
Journal:  PLoS Pathog       Date:  2016-02-25       Impact factor: 6.823

9.  An extrafollicular pathway for the generation of effector CD8(+) T cells driven by the proinflammatory cytokine, IL-12.

Authors:  Suhagi Shah; Gijsbert M Grotenbreg; Amariliz Rivera; George S Yap
Journal:  Elife       Date:  2015-08-05       Impact factor: 8.140

Review 10.  T-bet and Eomesodermin in NK Cell Development, Maturation, and Function.

Authors:  Federico Simonetta; Amandine Pradier; Eddy Roosnek
Journal:  Front Immunol       Date:  2016-06-20       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.